New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Medications
26 minutes ago |
not rated yet |
0
FDA has safety concerns on Merck insomnia drug
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
Medications
May 20, 2013 |
not rated yet |
0
Higher prices for MS drug help drug firm Merck
(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.
Other
May 14, 2013 |
not rated yet |
0
Drugmakers, health groups bring poor girls vaccine
Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer.
Medications
May 09, 2013 |
not rated yet |
0
Merck says FDA reviewing its ragweed allergy therapy
Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, ...
Medications
May 08, 2013 |
not rated yet |
0
Genetic variant may explain weight loss post-RYGB surgery
(HealthDay)—A genetic variant associated with weight loss after Roux-en-Y gastric bypass (RYGB) surgery has been identified, according to a study published in the May 2 issue of the American Journal of ...
Genetics
May 07, 2013 |
not rated yet |
0
Generic competition cuts Merck's Q1 sales, profit
Drugmaker Merck & Co. is reporting lower first-quarter results and cutting its 2013 profit forecast by 15 cents a share. It also is announcing a huge share buyback, up to $15 billion worth of its stock.
Medications
May 01, 2013 |
not rated yet |
0
Is a better sleeping pill on the way?
(HealthDay)—A new class of sleep medications appears to help people fall asleep without causing grogginess the next day, researchers say.
Medical research
Apr 03, 2013 |
4.5 / 5 (6) |
1
|
US probes new pancreas risks with diabetes drugs (Update)
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Medications
Mar 14, 2013 |
not rated yet |
0
ACC: Niacin/Laropiprant no benefit in vascular disease
(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious ...
Cardiology
Mar 12, 2013 |
not rated yet |
0
Niacin therapy unhelpful, occasionally harmful, study says
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.
Cardiology
Mar 09, 2013 |
4 / 5 (1) |
0
Merck Q4 net profit more than doubles
Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.
Other
Mar 07, 2013 |
2 / 5 (1) |
0
Generic competition, charges cut Merck Q4 profit (Update)
Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans to seek approval of a key experimental osteoporosis drug.
Other
Feb 01, 2013 |
not rated yet |
0
First OTC drug approved for women with overactive bladder
(HealthDay)—The drug Oxytrol has been approved by the U.S. Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder.
Medications
Jan 25, 2013 |
not rated yet |
0
How cervical cancer vaccines came to be
(HealthDay)—The cervical cancer vaccine has turned into one of the biggest success stories in the field.
Cancer
Jan 19, 2013 |
5 / 5 (1) |
0
